• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

囊性纤维化痰液:纳米球转运的障碍。

Cystic fibrosis sputum: a barrier to the transport of nanospheres.

作者信息

Sanders N N, De Smedt S C, Van Rompaey E, Simoens P, De Baets F, Demeester J

机构信息

Faculties of Pharmacy, Veterinary Medicine, and Medicine, Ghent University, Ghent, Belgium.

出版信息

Am J Respir Crit Care Med. 2000 Nov;162(5):1905-11. doi: 10.1164/ajrccm.162.5.9909009.

DOI:10.1164/ajrccm.162.5.9909009
PMID:11069833
Abstract

Cystic fibrosis (CF) is characterized by the presence of a viscoelastic mucus layer in the upper airways and bronchi. The underlying problem is a mutation in the gene encoding the cystic fibrosis transmembrane conductance regulator protein. Clinical studies of gene transfer for CF are ongoing. For gene delivery to the airways of CF patients to be effective, the mucus covering the target cells must be overcome. We therefore examined the extent to which CF sputum presents a physical barrier to the transport of nanospheres of a size comparable to that of lipoplexes and other transfection systems currently being clinically evaluated for CF gene therapy. We observed that an extremely low percentage of nanospheres (< 0.3%) moved through a 220-microm-thick CF sputum layer after 150 min. The largest nanospheres studied (560 nm) were almost completely blocked by the sputum, whereas the smaller nanospheres (124 nm) were retarded only by a factor of 1.3 as compared with buffer. Surprisingly, the nanospheres diffused significantly more easily through the more viscoelastic sputum samples. We hypothesize that the structure of the network in sputum becomes more macroporous when the sputum becomes more viscoelastic. Sputum from a patient with chronic obstructive pulmonary disease retarded the transport of nanospheres to the same extent as did CF sputum. When directly mixed with CF sputum, recombinant human deoxyribonuclease I moderately facilitated the transport of nanospheres through CF sputum.

摘要

囊性纤维化(CF)的特征是在上呼吸道和支气管中存在粘弹性粘液层。根本问题是编码囊性纤维化跨膜传导调节蛋白的基因发生突变。针对CF的基因转移临床研究正在进行中。为了使向CF患者气道的基因递送有效,必须克服覆盖靶细胞的粘液。因此,我们研究了CF痰液对大小与目前正在CF基因治疗中进行临床评估的脂质体和其他转染系统相当的纳米球运输构成物理屏障的程度。我们观察到,150分钟后,极低百分比的纳米球(<0.3%)穿过了220微米厚的CF痰液层。所研究的最大纳米球(560纳米)几乎完全被痰液阻断,而较小的纳米球(124纳米)与缓冲液相比仅被延迟了1.3倍。令人惊讶的是,纳米球在粘性更大的痰液样本中扩散得明显更容易。我们推测,当痰液变得更具粘性时,痰液中网络结构会变得更具大孔性。慢性阻塞性肺疾病患者的痰液对纳米球运输的阻碍程度与CF痰液相同。当与CF痰液直接混合时,重组人脱氧核糖核酸酶I适度促进了纳米球通过CF痰液的运输。

相似文献

1
Cystic fibrosis sputum: a barrier to the transport of nanospheres.囊性纤维化痰液:纳米球转运的障碍。
Am J Respir Crit Care Med. 2000 Nov;162(5):1905-11. doi: 10.1164/ajrccm.162.5.9909009.
2
Actin limits enhancement of nanoparticle diffusion through cystic fibrosis sputum by mucolytics.肌动蛋白限制了黏液溶解剂增强纳米颗粒在囊性纤维化痰液中的扩散。
Pulm Pharmacol Ther. 2007;20(6):708-17. doi: 10.1016/j.pupt.2006.08.008. Epub 2006 Sep 9.
3
Enhanced viscoelasticity of human cystic fibrotic sputum correlates with increasing microheterogeneity in particle transport.人类囊性纤维化痰液增强的粘弹性与颗粒运输中不断增加的微观异质性相关。
J Biol Chem. 2003 Dec 12;278(50):50393-401. doi: 10.1074/jbc.M309026200. Epub 2003 Sep 17.
4
Rheology of cystic fibrosis sputum after in vitro treatment with hypertonic saline alone and in combination with recombinant human deoxyribonuclease I.高渗盐水单独及联合重组人脱氧核糖核酸酶I体外处理后囊性纤维化痰液的流变学
Am J Respir Crit Care Med. 1997 Jul;156(1):173-7. doi: 10.1164/ajrccm.156.1.9512074.
5
Is cystic fibrosis mucus abnormal?囊性纤维化患者的黏液是否异常?
Pediatr Res. 1981 Feb;15(2):120-2. doi: 10.1203/00006450-198102000-00007.
6
On the transport of lipoplexes through cystic fibrosis sputum.关于脂质体复合物在囊性纤维化痰液中的转运
Pharm Res. 2002 Apr;19(4):451-6. doi: 10.1023/a:1015139527747.
7
Reduction in viscoelasticity in cystic fibrosis sputum in vitro using combined treatment with nacystelyn and rhDNase.使用N-乙酰半胱氨酸和重组人脱氧核糖核酸酶联合治疗对囊性纤维化痰液体外粘弹性的降低作用。
Pediatr Pulmonol. 1996 Sep;22(3):161-6. doi: 10.1002/(SICI)1099-0496(199609)22:3<161::AID-PPUL4>3.0.CO;2-S.
8
Improved clearability of cystic fibrosis sputum with dextran treatment in vitro.体外使用右旋糖酐治疗改善囊性纤维化痰液的清除能力。
Am J Respir Crit Care Med. 1998 Mar;157(3 Pt 1):710-4. doi: 10.1164/ajrccm.157.3.9703059.
9
The role of mucous glycoproteins in the rheologic properties of cystic fibrosis sputum.黏液糖蛋白在囊性纤维化痰液流变学特性中的作用。
Am Rev Respir Dis. 1990 Nov;142(5):1053-8. doi: 10.1164/ajrccm/142.5.1053.
10
Revisited physicochemical and transport properties of respiratory mucus in genotyped cystic fibrosis patients.基因分型囊性纤维化患者呼吸道黏液的物理化学和传输特性再探讨
Am J Respir Crit Care Med. 1997 Jul;156(1):166-72. doi: 10.1164/ajrccm.156.1.9606123.

引用本文的文献

1
Simulation of drug transport in airway surface liquid considering mucus flow and ciliary interaction.考虑黏液流动和纤毛相互作用的气道表面液体中药物转运模拟。
Sci Rep. 2025 Aug 30;15(1):31951. doi: 10.1038/s41598-025-16822-8.
2
FeO nanoparticles disrupt microstructure and reduce the viscoelasticity of simulated asthma airway mucus for potential airway mucus clearance applications.氧化亚铁纳米颗粒破坏模拟哮喘气道黏液的微观结构并降低其黏弹性,用于潜在的气道黏液清除应用。
Front Physiol. 2025 Jun 30;16:1566716. doi: 10.3389/fphys.2025.1566716. eCollection 2025.
3
Dermal formulation based on carbopol and Gum Arabic improves skin retention of indomethacin.
基于卡波姆和阿拉伯胶的皮肤制剂可提高吲哚美辛在皮肤中的保留率。
PLoS One. 2025 Jun 10;20(6):e0326051. doi: 10.1371/journal.pone.0326051. eCollection 2025.
4
Discovery of peptides for ligand-mediated delivery of mRNA lipid nanoparticles to cystic fibrosis lung epithelia.发现用于将mRNA脂质纳米颗粒通过配体介导递送至囊性纤维化肺上皮细胞的肽。
Mol Ther Nucleic Acids. 2024 Oct 28;35(4):102375. doi: 10.1016/j.omtn.2024.102375. eCollection 2024 Dec 10.
5
Synthetic mucus barrier arrays as a nanoparticle formulation screening platform.作为纳米颗粒制剂筛选平台的合成黏液屏障阵列
RSC Pharm. 2024 Apr 18;1(2):218-226. doi: 10.1039/d3pm00057e. eCollection 2024 Jun 18.
6
Novel inhalation therapy in pulmonary fibrosis: principles, applications and prospects.新型吸入疗法在肺纤维化中的应用:原理、应用及前景。
J Nanobiotechnology. 2024 Mar 29;22(1):136. doi: 10.1186/s12951-024-02407-6.
7
Mucus Structure, Viscoelastic Properties, and Composition in Chronic Respiratory Diseases.慢性呼吸系统疾病中的黏液结构、黏弹性特性和成分。
Int J Mol Sci. 2024 Feb 5;25(3):1933. doi: 10.3390/ijms25031933.
8
activity of novel apramycin-dextran nanoparticles and free apramycin against selected Dutch and Pakistani isolates.新型安普霉素-葡聚糖纳米颗粒和游离安普霉素对选定的荷兰和巴基斯坦分离株的活性。
Heliyon. 2023 Nov 25;9(12):e22821. doi: 10.1016/j.heliyon.2023.e22821. eCollection 2023 Dec.
9
Synthetic mucus barrier arrays as a nanoparticle formulation screening platform.作为纳米颗粒制剂筛选平台的合成黏液屏障阵列
bioRxiv. 2023 Nov 30:2023.11.29.569212. doi: 10.1101/2023.11.29.569212.
10
Therapeutic Effects of Hydrogel Formulations Incorporating Troxipide Nanoparticles on Oral Mucositis in Hamsters.载有曲匹匹特纳米粒的水凝胶制剂对仓鼠口腔黏膜炎的治疗作用。
Drug Des Devel Ther. 2023 Nov 15;17:3349-3361. doi: 10.2147/DDDT.S433776. eCollection 2023.